Material Safety Data Sheet
Date Prepared: 10/17/03 X-GEN Pharmaceuticals
Prepared By: RC Park PO Box 445
Technical Assistance: 607-562-2700 Big Flats, NY 14814
ERYTHROMYCIN
IDENTIFICATION
Common Name: Erythromycin
Chemical Name: Erythromycin
Synonym: Erythromycin A Formula: C37H67NO13
CAS Number: 114-07-8 RTECS Number: KF4375000
Chemical Family: A Macrolide antibiotic
Therapeutic Category: Antibacterial
INGREDIENT INFORMATION
Principle Components Percent Exposure Limits
Erythromycin 100 % n/f
HEALTH HAZARD INFORMATION
Usual Adult Dose: The usual oral adult dose of erythromycin is 250 to 500 mg per day in divided
doses, not to exceed 4 grams daily. Erythromycin is also administered topically to the eye as a 0.5 to
1% ointment and to the skin as a 2 to 4% solution.
Adverse Effects: Adverse effects may include skin rash, redness, or itching; liver toxicity (fever,
nausea, skin rash, severe stomach pain, unusual tiredness or weakness, yellow eyes or skin,
vomiting); abdominal or stomach cramping or discomfort; diarrhea; nausea; vomiting; sore mouth or
tongue; white patches in mouth or on tongue; and genital itching or discharge. Possible allergic
reaction to material if inhaled, ingested or in contact with skin.
Overdose Effects: Symptoms of overdose include ringing in ears, severe gastrointestinal discomfort,
transient auditory impairment, and irregular heartbeat.
Acute: Possible eye, skin, gastrointestinal and/or respiratory tract irritation.
Chronic: Possible hypersensitization, hepatoxicity, hearing loss, and superinfection.
Inhalation: May cause irritation. Remove to fresh air.
Eye: Causes mild irritation. Flush with copious quantities of water.
Skin: Causes irritation. Flush with copious quantities of soap and water.
n/f = not found
ERYTHROMYCIN
HEALTH HAZARD INFORMATION CONTINUED
Ingestion: May cause irritation and bitter taste. Flush out mouth with water. This material is variably
absorbed from the gastrointestinal tract.
Medical Conditions Aggravated by Exposure: Hypersensitivity to material, impaired liver
function, acute porphyria, and a history of cardiac arrhythmias or QT prolongation.
Cross Sensitivity: Persons sensitive to other erythromycins or macrolides may be sensitive to this
material also.
Pregnancy Comments: Adequate and well-controlled pregnancy studies have not been done in
humans. Erythromycin showed no evidence of birth defects or any other adverse effects on
reproduction in studies in female rats.
Pregnancy Category: B
FIRST AID MEASURES
General: Remove from exposure. Remove contaminated clothing. Persons developing serious
hypersensitivity (anaphylactic) reactions must receive immediate medical attention. If person is not
breathing give artificial respiration. If breathing is difficult give oxygen. Obtain medical attention.
Overdose Treatment: Overdose treatment may include the following:
1. Evacuate the stomach to eliminate unabsorbed material.
2. Administer epinephrine, corticosteroids, and antihistamines for allergic reactions.
3. Use supportive measures as needed.
4. Hemodialysis or peritoneal dialysis does not remove erythromycins. [USP DI 2001]
TOXICOLOGICAL INFORMATION
Oral Rat: LD50: 4600 mg/kg
Oral Mouse: LD50: 2580 mg/kg
Irritancy Data: n/f
Target Organ(s): Liver and gastrointestinal system
Listed as a Carcinogen? NTP: No IARC: No OSHA: No
Other: No
FIREFIGHTING MEASURES
Flash Point: n/f Upper Flammable Limit: n/f
Auto-Ignition Temperature: n/f Lower Flammable Limit: n/f
Extinguisher Media: Water spray, dry chemical, carbon dioxide or foam as appropriate for
surrounding fire and materials.
2
n/f = not found
ERYTHROMYCIN
FIREFIGHTING MEASURES CONTINUED
Fire and Explosion Hazards: This material is assumed to be combustible. As with all dry powders it
is advisable to ground mechanical equipment in contact with dry material to dissipate the potential
buildup of static electricity.
Firefighting Procedures: As with all fires, evacuate personnel to a safe area. Firefighters should use
self-contained breathing equipment and protective clothing.
PHYSICAL HAZARDS
Conditions to Avoid: Avoid exposure to heat and moisture.
Incompatibilities: Volatile organic solvents and acids.
Decomposition Products: When heated to decomposition material emits toxic fumes of NOx. Emits
toxic fumes under fire conditions.
Stable? Yes Hazardous Polymerization? No
HANDLING / SPILL / DISPOSAL MEASURES
Handling: As a general rule, when handling USP Reference Standards avoid all contact and
inhalation of dust, mists, and/or vapors associated with the material. Wash thoroughly after handling.
Storage: Store in tight container as defined in the USP-NF. This material should be handled and
stored per label instructions to ensure product integrity. Store in a freezer.
Spill Response: Wear approved respiratory protection, chemically compatible gloves and protective
clothing. Wipe up spillage or collect spillage using a high efficiency vacuum cleaner. Avoid breathing
dust. Place spillage in appropriately labeled container for disposal. Wash spill site.
Disposal: Dispose of waste in accordance with all applicable Federal, State and local laws.
EXPOSURE CONTROLS / PERSONAL PROTECTION
Respiratory Protection: When working with small quantities in a well-ventilated area, respiratory
protection may not be required. The use of an approved dust mask is recommended.
Ventilation: No special ventilation requirements.
Gloves: Rubber
Eye Protection: Safety Glasses
Protective Clothing: Protect exposed skin.
3
n/f = not found
ERYTHROMYCIN
PHYSICAL AND CHEMICAL PROPERTIES
Appearance and Odor: White to pale yellow crystalline powder; odorless or practically odorless.
Melting Point: 135 - 140掳 C (resolidifies w/second m.p. @ 190 - 193掳 C)
Solubility in Water: Very slightly soluble Vapor Density: n/f
Solubility in Water: n/f Evaporation Rate: n/f
Boiling Point: n/f Evaporation Rate: n/f
Specific Gravity: n/f Reactivity in Water: n/f
Vapor Pressure: n/f % Volatile by Volume: n/f
4
n/f = not found
|